3DXCM : DexCom's Options: A Look at What the Big Money is Thinking
The general mood among these heavyweight investors is divided, with 12% leaning bullish and 50% bearish. Among these notable ...
MedTech Dive11h
Dexcom rejects claims of unauthorized device changes in FDA warning letter
A company spokesperson said Dexcom plans to resolve the agency's concerns but stated no design changes were made to its ...
DexCom Inc. stock underperforms Thursday when compared to competitors
Shares of DexCom Inc. slipped 3.69% to $69.47 Thursday, on what proved to be an all-around poor trading session for the stock ...
Zacks Investment Research on MSN19h
DXCM Stock Falls as FDA Warnings Raise Concern for 15-Day G7 Approval
DexCom DXCM is facing regulatory scrutiny following a warning letter recently posted by the FDA. This could affect the ...
Digital information world22h
New Study Explores Noninvasive Glucose Monitoring, Bringing Diabetes Care a Step Closer to Innovation
A new study published in Nature examined the potential of noninvasive blood glucose monitoring devices on 50 people with type 2 diabetes over two days. Raman Spectroscopy used an 830nm near-infrared ...